Save up to 30% on Elsevier print and eBooks with free shipping. No promo code needed.
Save up to 30% on print and eBooks.
Advances in Cancer Research
1st Edition, Volume 95 - July 24, 2006
Editors: George F. Vande Woude, George Klein
Language: English
Hardback ISBN:9780120066957
9 7 8 - 0 - 1 2 - 0 0 6 6 9 5 - 7
eBook ISBN:9780080464480
9 7 8 - 0 - 0 8 - 0 4 6 4 4 8 - 0
The Advances in Cancer Research series provides invaluable information on the exciting and fast-moving field of cancer research. This volume presents outstanding and origin…Read more
Purchase options
LIMITED OFFER
Save 50% on book bundles
Immediately download your ebook while waiting for your print delivery. No promo code is needed.
The Advances in Cancer Research series provides invaluable information on the exciting and fast-moving field of cancer research. This volume presents outstanding and original reviews on a variety of topics including NY-ESO-1: review of an immunogenic tumor antigen; Order, disorder, death: lessons from a superorganism; Control of differentiation in progression of epithelial tumors; Cancer vaccines: preclinical studies and novel strategies; Clinical results of vaccine therapy for cancer: learning from history for improving the future; Immunodominance and immunodomination: critical factors in developing effective CD8+ T-cell based cancer vaccines; NK cell receptors as tools in cancer immunotherapy; Innate immune recognition and suppression of tumors; Inhibitors of the HSP90 molecular chaperone: current status.
Researchers and students in the basic and clinical science of cancer biology and oncology, plus related areas in genetics, immunology, pharmacology, cell biology and molecular biology.
NY-ESO-1: Review of an Immunogenic Tumor Antigen. Order, Disorder, Death: Lessons from a Superorganism. Control of Differentiation in Progression of Epithelial Tumors. Cancer Vaccines: Preclinical Studies and Novel Strategies. Clinical Results of Vaccine Therapy for Cancer: Learning from History for Improving the Future. Immunodominance and Immunodomination: Critical Factors in Developing Effective CD8+ T-Cell Based Cancer Vaccines. NK Cell Receptors as Tools in Cancer Immunotherapy. Innate Immune Recognition and Suppression of Tumors. Inhibitors of the HSP90 Molecular Chaperone: Current Status.
No. of pages: 376
Language: English
Edition: 1
Volume: 95
Published: July 24, 2006
Imprint: Academic Press
Hardback ISBN: 9780120066957
eBook ISBN: 9780080464480
GV
George F. Vande Woude
Affiliations and expertise
Director, Van Andel Research Institute, Grand Rapids, MI, USA
NCI-Frederick Cancer Research Facility Frederick, Maryland
ABL-Basic Research Program, NCI-Frederick Cancer Research and Development Center, Frederick, Maryland